BusinessPhoto: Business StandardRPG Life Sciences Plans ₹500 Crore Acquisition from Capital Pool
Mumbai-based RPG Life Sciences plans to use about ₹500 crore from its committed capital pool to acquire another asset within 12 months. The company has already deployed ₹200 crore from a ₹700-crore pool and seeks assets with USFDA approval or operational synergies. RPG aims to grow its API business by 25% annually over five years through organic growth and acquisitions, following recent purchases of Actis Therapeutics and Raghav Lifesciences.
Business Standard··Mumbai




